Abstract:Prion diseases are fatal neurodegenerative disorders where the formation of amyloids is thought to be infectious by templating their conformation on to natively-folded counterparts. Postulated nearly four decades ago, the search for the mechanism behind the conformational templating has proceeded to no avail. Here, we extend the thermodynamic hypothesis of protein folding (Anfinsen's dogma) to the amyloid phenomenon and illustrate that the amyloid conformation (cross-β) is one of two conformational states that are thermodynamically accessible to any protein sequence depending on concentration. A protein spontaneously assumes its native conformation below supersaturation and the amyloid cross-β conformation above supersaturation. The information to adopt the native conformation and the amyloid conformation is present in the primary sequence and the backbone of the protein, respectively, and does not require templating. The rate-limiting step for proteins to adopt the cross-β conformation of amyloid is termed nucleation, which can be catalyzed by surfaces (heterogeneous nucleation) or preformed amyloid fragments (seeding). Irrespective of the nucleation pathway, once triggered, amyloid formation proceeds spontaneously in fractal-like fashion, where the surfaces of the growing fibrils act as heterogeneous nucleation catalysts for new fibrils, a phenomenon known as secondary nucleation. This pattern is in contrast to the linear growth assumptions that the prion hypothesis necessitates for faithful prion strain replication. Additionally, the cross-β conformation buries the majority of the protein side chain inside the fibrils, making the fibrils inert, generic, and extremely stable. As such, the source of toxicity in prion disorders may come to a greater extent from the loss of proteins in their normal, soluble, and therefore functional state rather than from their transformation into stable, insoluble, nonfunctioning amyloids.

Prion-like Aggregation of the Heptapeptide GNNQQNY into Amyloid Nanofiber is Governed by Configuration Entropy.

Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35

The allure and pitfalls of the prion-like aggregation in neurodegeneration

A variational model for oligomer-formation process of GNNQQNY peptide from yeast prion protein Sup35.

Effect Of Amino Acid Sequence Rearrangment On Prion Aggregation: Molecular Dynamics Simulations Of An Amyloid-Forming Peptide From The Yeast Prion Sup35p

Molecular Dynamics Simulations on the Oligomer-Formation Process of the GNNQQNY Peptide from Yeast Prion Protein Sup35.

N-terminal Prion Protein Peptides (prp(120–144)) Form Parallel In-Register Β-Sheets Via Multiple Nucleation-Dependent Pathways.

Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

Polymorphism Of Amyloid Fibrils Formed By A Peptide From The Yeast Prion Protein Sup35: Afm And Tip-Enhanced Raman Scattering Studies

Exploring the Early Steps of Aggregation of Amyloid-Forming Peptide Kffe

Amyloid Nucleation and Hierarchical Assembly of Ure2p Fibrils: ROLE OF ASPARAGINE/GLUTAMINE REPEAT AND NONREPEAT REGIONS OF THE PRION DOMAIN

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

The Positively Charged Cluster in the N-terminal Disordered Region may Affect Prion Protein Misfolding: Cryo-EM Structure of Hamster PrP(23–144) Fibrils

Cryo-EM Structure of an Amyloid Fibril Formed by Full-Length Human Prion Protein

Role of Monomer Arrangement in the Amyloid Self-Assembly.

Sequence dependent aggregation of peptides and fibril formation

Self-Assembly of Polypeptides into Left-Handedly Twisted Fibril-Like Structures

Mapping the Broad Structural and Mechanical Properties of Amyloid Fibrils.

Short Peptide Amyloid Organization: Stabilities And Conformations Of The Islet Amyloid Peptide Nfgail

An optimization strategy on prion AGAAAAGA amyloid fibril molecular modeling